Maximize Your Impact At BIO CEO & Investor Conference 2026
The BIO CEO & Investor Conference 2026, taking place March 2–3 in Miami, Florida, is one of the life sciences industry’s most influential investor-focused events. It brings together biotech executives, institutional investors, private equity firms, and clinical research organizations for purposeful networking and high-value discussions centered on capital allocation and strategic partnerships.
Decisions at this conference shape the future of drug development, biotech investment, and healthcare innovation. Attendees are often executive-level leaders, including CEOs, CFOs, investor relations officers, and portfolio managers, making the event a key site for budget planning, funding allocation, and evaluating new technologies. For commercial teams, this is a moment to influence buying decisions and build lasting strategic relationships. With access to Vendelux’s enriched attendee list, your team can prioritize outreach to senior stakeholders based on company type, funding stage, therapeutic area, and historical engagement with partners.
How Sales, Marketing and Revops Teams Can Use This Attendee List
The BIO CEO & Investor Conference draws senior biotech and investor audiences who are active decision-makers in funding, collaborations, and clinical development. This enriched conference attendee list helps commercial teams move quickly and strategically.
Use attendee data to segment contacts by company size, funding round, or therapeutic focus, and align outreach accordingly. Focus initial messaging on the key investment themes relevant to that attendee’s portfolio or business need. Identify budget owners in advance to secure meetings before calendars fill. Use pre-event outreach tied to investor concerns—such as milestones, market readiness, or licensing opportunities—to stand out.
During the conference, connect in person with relevant leads already identified through the Vendelux platform, and log every interaction for personalized follow-ups. Post-event, leverage those conversations by following up with metrics-driven content, partnership overviews, or targeted investment decks that reflect shared interests. Done right, this use of the enriched attendee list makes it easier to get more meetings, build trust earlier, and turn short interactions into multi-year collaborations.
Timing Is Everything
The BIO CEO & Investor Conference 2026 is scheduled for March 2–3, 2026. With investors and executives planning their schedules months ahead, early engagement is critical. Gig-caliber meetings don’t happen without preparation.
Vendelux allows your sales and marketing teams to access the attendee list well in advance so you can align outreach with prospect intent and scheduling. Start connecting with high-fit leads as early as Q3 2025, ensuring your team is already in conversations by the time the event opens. This lets you secure interest, confirm meetings, and inform your at-event engagement with more context.
What’s Included In The BIO CEO & Investor Conference 2026 Attendee List?
Vendelux provides insight into expected attendees through a blend of organizer data and our proprietary predictive analytics. Users can also upload a list of target accounts to detect exact matches within the existing conference attendee file.
The enriched list includes first and last names, job titles, company names, company websites, city, state, and country location data, LinkedIn profiles, along with verified email addresses and phone numbers when available.
Where Is BIO CEO & Investor Conference 2026?
The event will be held in Miami, Florida, United States. Final venue details are to be announced.
When Is BIO CEO & Investor Conference 2026?
BIO CEO & Investor Conference 2026 is scheduled for March 2–3, 2026.
What Type Of Event Is BIO CEO & Investor Conference 2026?
BIO CEO & Investor Conference 2026 is a leading investment and partnering event for the biotechnology sector. The program features fireside chats, one-on-one meetings, and expert-led panels addressing market trends, therapeutic breakthroughs, and capital strategy. It offers a focused environment for deal-making between innovators and financial stakeholders.
How Many People Attend BIO CEO & Investor Conference 2026?
The event attracts more than 1,200 attendees annually, with participants representing over 30 countries. Most attendees are director-level and above, including C-suite executives, managing partners, and senior investment professionals across biotech, pharma, and venture capital.
